Company Filing History:
Years Active: 2014
Title: Innovations of Zhongru Guo
Zhongru Guo is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tyrosine kinase inhibitors. His work is characterized by a focus on innovative compounds that have the potential to impact medical treatments.
Latest Patents
Zhongru Guo holds 1 patent for his invention titled "4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors." This patent relates to the development of 4-(substituted anilino)-quinazoline derivatives that serve as effective tyrosine kinase inhibitors. The invention details compounds of formula I, including their preparation methods, pharmaceutical compositions, and uses. The compounds are designed to be effective in inhibiting tyrosine kinases, which play a crucial role in various cellular processes.
Career Highlights
Zhongru Guo is associated with Qilu Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at this company underscores his commitment to innovation in the pharmaceutical industry.
Collaborations
Zhongru Guo has collaborated with Chuanwen Fan, contributing to the advancement of their shared research interests.
Conclusion
Zhongru Guo's innovative work in the field of pharmaceuticals, particularly with his patent on tyrosine kinase inhibitors, highlights his role as a significant contributor to medical science. His ongoing efforts at Qilu Pharmaceutical Co., Ltd. continue to pave the way for future advancements in this critical area.